Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.06.2018 | Case report

Ticlopidine

Derangement of liver function tests: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

A 56-year-old woman developed deranged liver function tests during treatment with ticlopidine for atherothrombotic disease prophylaxis [route and duration of treatment to reaction onset not stated]. …
Literatur
Zurück zum Zitat Feghaly J, et al. Aspirin safety in glucose-6-phosphate dehydrogenase deficiency patients with acute coronary syndrome undergoing percutaneous coronary intervention. [Review]. BMJ Case Reports 2017: 9 Oct 2017. Available from: URL: http://doi.org/10.1136/bcr-2017-220483 - United Kingdom Feghaly J, et al. Aspirin safety in glucose-6-phosphate dehydrogenase deficiency patients with acute coronary syndrome undergoing percutaneous coronary intervention. [Review]. BMJ Case Reports 2017: 9 Oct 2017. Available from: URL: http://​doi.​org/​10.​1136/​bcr-2017-220483 - United Kingdom
Metadaten
Titel
Ticlopidine
Derangement of liver function tests: case report
Publikationsdatum
01.06.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-48395-3

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Dasatinib

Case report

Icotinib

Case report

Ciclosporin

Case report

Afatinib